Back to top

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Apr 17, 2014 06:05 PM ET

 Add to portfolio

$175.92 USD

-0.25 (-0.14%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2014) 7.22
Objective* Equity - Sector Health
Peer* HL MG

*Key

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 37.88
Net Assets (Mil $) 3/31/2014 9,388.05
%Turnover 3/31/2014 42.00

Allocation

% of Portfolio
Large Growth 19.77
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 7.62
Foreign Bond 25.95
High Yield Bond 0.00

Sector / Country Weightings

As of 3/31/2014 % of Portfolio
Health 54.50
Services 25.97
Other 10.27
Industrial Cyclical 8.87
Technology 0.39

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2013)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 16.62 1,291.90
AMGEN INC 9.92 770.75
BIOGEN IDEC INC 8.37 650.60
CELGENE CORP 5.83 452.89
REGENERON PHARMACEUTICALS 4.22 328.16
ALEXION PHARMACEUTICALS I 4.18 325.20
VERTEX PHARMACEUTICALS IN 3.16 245.72
PHARMACYCLICS INC 2.00 155.59
AEGERION PHARMACEUTICALS 1.98 154.17

Stock Holding % of Net Assets

As Of 11/30/2013
Total Issues 148
Avg. P/E 42.74
Avg. P/Book 5.78
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 43,046

Risk

3 Year 5 Year 10 Year
Beta 0.94 0.84 0.78
Alpha 23.87 11.76 8.35
R Squared 0.31 0.32 0.34
Std. Dev. 21.28 20.93 20.01
Sharpe 1.95 1.53 2.00